We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Big Cypress Acquisition Corporation | NASDAQ:BCYP | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 8.44 | 7.87 | 8.10 | 0 | 01:00:00 |
Delaware
|
001-39871
|
85-3899721
|
(State or Other Jurisdiction
of Incorporation) |
(Commission File Number)
|
(IRS Employer
Identification No.) |
2100 East 54th Street North
|
||
Sioux Falls, South Dakota
|
57104
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Registrant’s Telephone Number, Including Area Code: 605 679-6980
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
Symbol(s) |
Name of each exchange on which registered
|
||
Common stock, $0.0001 par value per share
|
SABS
|
The NASDAQ Stock Market LLC
|
||
Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
|
SABSW
|
The NASDAQ Stock Market LLC
|
Exhibit Number
|
Description
|
99.1
|
Press Release of the Company, dated April 26, 2023 |
104
|
Cover Page Interactive Data File-the cover page XBRL tags are embedded within the Inline XBRL document.
|
SAB Biotherapeutics, Inc.
|
|||
Date:
|
April 28, 2023
|
By:
|
/s/ Eddie J. Sullivan
|
Eddie J. Sullivan
Chief Executive Officer |
1 Year Big Cypress Acquisition Chart |
1 Month Big Cypress Acquisition Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions